Most Expensive
request_quoteIndulge in the exquisite details and unparalleled quality of the most expensive products and assets that define luxury living.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardPE Ratio | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ONFO ONFOWOnfolio Holdings | $0.15 | $0.15 | 0.00% | $1.12M | 1.00 | 0.14 | - | Neutralremove | - | -3.12% | |||||
BTMBitcoin Depot Inc. - Class A Common Stock | $3.32 | -$0.16 | arrow_drop_down4.70% | $48.31M | 3.00M | 3.50 | - | Sellkeyboard_arrow_down | - | 75.00% | |||||
GRNDGrindr | $23.95 | $0.21 | arrow_drop_up0.88% | $4.60B | 959.38K | 23.93 | - | Neutralremove | - | 156.97% | |||||
GHSIGuardion Health Sciences | $3.25 | $0.01 | arrow_drop_up0.30% | $4.34M | 91.68K | 3.26 | - | Neutralremove | - | -64.28% | |||||
IZM IZMICZOOM Group Inc. - Class A Ordinary Shares | $2.43 | $0.02 | arrow_drop_up0.97% | $29.56M | 15.71K | 2.42 | - | Neutralremove | - | 14.31% | |||||
 QSQuantumScape Corporation | $3.97 | $0.02 | arrow_drop_up0.62% | $2.38B | 6.57M | 3.94 | - | Neutralremove | - | -31.10% | |||||
RKDAArcadia Biosciences | $4.21 | $0.03 | arrow_drop_up0.83% | $5.29M | 3.60K | 4.25 | - | Neutralremove | - | 51.61% | |||||
EDITEditas Medicine | $1.53 | -$0.10 | arrow_drop_down6.17% | $116.77M | 665.71K | 1.53 | - | Neutralremove | - | -74.50% | |||||
RGFThe Real Good Food Company | $1.25 | -$2.23 | arrow_drop_down62.37% | $2.17M | 1.47M | 1.75 | - | Neutralremove | - | -81.06% | |||||
EXKEndeavour Silver | $3.62 | $0.11 | arrow_drop_up3.26% | $967.06M | 13.27M | 3.57 | - | Neutralremove | - | -3.33% | |||||
SABRSabre | $2.54 | -$0.03 | arrow_drop_down1.35% | $1.14B | 4.14M | 2.53 | - | Neutralremove | - | -12.84% | |||||
LGVNLongeveron | $1.32 | -$0.05 | arrow_drop_down3.63% | $21.01M | 48.90K | 1.34 | - | Neutralremove | - | 14.22% | |||||
UPC UPCUniverse Pharmaceuticals | $4.65 | -$0.85 | arrow_drop_down15.45% | $2.76M | 50.97K | 5.01 | - | Neutralremove | - | -99.68% | |||||
YMABY-mAbs Therapeutics | $4.26 | $0.04 | arrow_drop_up0.96% | $174.79M | 143.82K | 4.15 | - | Neutralremove | - | -66.80% | |||||
VSACWVision Sensing Acquisition | $0.00 | -$0.00 | arrow_drop_down33.33% | $0.00 | 74.51K | 0.00 | - | Neutralremove | - | - | |||||
BIPCBrookfield Infrastructure | $39.66 | $0.59 | arrow_drop_up1.52% | $4.63B | 487.26K | 39.56 | - | Neutralremove | 4.02% | 10.90% | |||||
FATEFate Therapeutics | $1.17 | -$0.03 | arrow_drop_down2.91% | $115.77M | 514.40K | 1.16 | - | Neutralremove | - | -67.80% | |||||
SESSES AI | $0.94 | -$0.02 | arrow_drop_down2.10% | $335.63M | 8.26M | 0.95 | - | Neutralremove | - | -24.32% | |||||
SNSESensei Biotherapeutics | $0.29 | -$0.00 | arrow_drop_down2.50% | $8.77M | 68.00K | 0.29 | - | Neutralremove | - | -78.52% | |||||
MITAColiseum Acquisition | $11.51 | $11.51 | 0.00% | $63.73M | 35.85K | 11.34 | - | Neutralremove | - | - |
Showing 4781-4800 of 4978
Results per page:
About Most Expensive
Discover the world of the most expensive stocks, where share prices reach extraordinary heights. These stocks command premium valuations, reflecting investor confidence and perceived value in the companies.
Investors seeking prestigious opportunities may find these high-priced stocks alluring, as they often represent established and successful companies with strong market positions.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools